Role of tumor necrosis factor in toluene diisocyanate asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 4, 2002, Pages 396-405

  Matheson, Joanna M ^a   Lemus, Ranulfo ^a   Lange, Robert W ^a   Karol, Meryl H ^a   Luster, Michael I ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 0036787915     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4614     Document Type: Article

References (52)

1. Tee, R. D., P. Cullinan, J. Welch, S. P. Burge, and A. J. Newman-Taylor. 1998. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101:709-715.
2. Scheerens. H., T. L. Buckley, T. Muis, H. Van Loveren, and F. P. Nijkamp. 1996. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br. J. Pharmacol. 119:1665-1671.
3. Raulf-Heimsoth, M., and X. Baur. 1998. Pathomechanisms and pathophysiology of isocyanate-induced diseases: summary of present knowledge. Am. J. Ind. Med. 34:137-143.
4. Mapp, C. E., M. Saetta, P. Maestrelli, A. D. Stefano. P. Chitano, P. Boschetto, A. Ciaccia. and L. M. Fabbri. 1994. Mechanisms and pathology of occupational asthma. Eur. Respir. J. 7:544-554.
5. Shah, A., M. K. Church, and S. T. Holgate. 1995. Tumor necrosis factor alpha: a potential mediator of asthma. Clin. Exp. Allergy 25:1038-1044.
6. Oosterhout, A. J. M. V., and F. P. Nijkamp. 1993. Role of cytokines in bronchial hyperresponsiveness. Pulm. Pharmacol. 6:225-236.
7. Kips, J. C., J. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332-336.
8. Lukacs, N. W., R. M. Strieter, S. W. Chensue, M. Widmer, and S. L. Kunkel. 1995. TNF-a mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154:5411-5417.
9. Worrall, N. K, K. Chang, W. S. LeJeune, T. P. Misko, P. M. Sullivan, J. T. B. Ferguson, and J. R. Williamson. 1998. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am. J. Physiol. 273:H2565-2574.
10. Cumberbatch, M., and I. Kimber. 1995. Tumor necrosis factor-a is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31-35.
11. Hessel, E. M., A. J. M. V. Oosterhout, I. V. Ark, B. V. Esch, G. Hofman, H. V. Loveren, H. F. J. Savelkoul, and F. P. Nijkamp. 1997. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16:325-334.
12. Rudman, D. G., M. W. Moore, J. S. Tepper, M. C. Aldrich, J. W. Pfeiffer, H. Hogenesch, and D. B. Tumas. 2000. Modulation of allergic inflammation in mice deficient in TNF receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L1047-L1057.
13. Luster, M. I., D. R. Germolec, T. Yoshida, F. Kayama, and M. Thompson. 1994. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19:480-488.
14. Karol, M. H. 1998. Target organs and systems: methodologies to assess immune system function. Environ. Health Perspect. 106(Supp 2):533-540
15. Satoh, T., J. A. Kramarik, D. J. Tollerud, and M. H. Karol. 1995. A murine model for assessing the respiratory hypersensitivity potential of chemical allergens. Toxicol. Lett. 78:57-66.
16. Schwarze, J., G. Cieslewicz, E. Hamelmann. A. Joetham, L. D. Shultz, M. C. Lamers, and E. W. Gelfand. 1999. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J. Immunol. 162:2997-3004.
17. Simeonova, P. P., and M. I. Luster. 1996. Asbestos induction of nuclear transcription factors and interleukin 8. Am. J. Respir. Cell Mol. Biol. 15:787-795.
18. Wilmer, J. L., F. G. Burleson, F. Kayama, J. Kanno, and M. I. Luster. 1994. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J. Invest. Dermatol. 102:915-922.
19. Caux, C. 1998. Pathways of development of human dendritic cells. Eur. J. Dermatol. 8:375-384.
20. Karol, M. H., R. Jin, and R. C. Lantz. 1997. Immunohistochemical detection of toluene diisocyanate (TDI) adducts in pulmonary tissue of guinea pigs following inhalation exposure. Inhal. Toxicol. 9:63-83.
21. Matheson, J. M., R. W. Lange, R. Lemus. M. H. Karol, and M. I. Luster. 2000. Importance of inflammatory and immune components in a mouse model of airway reactivity to Toluene Diisocyanate (TDI). Clin. Exp. Allergy (In press)
22. Bernstein, J. A., J. Munson, Z. L. Lummus. K. Balakrishnan, and G. Leikauf. 1997. T-cell receptor V[beta] gene segment expression in diisocyanate-induced occupational asthma. J. Allergy Clin. Immunol. 99:245-250.
23. Wang, B., H. Fujisawa, L. Zhuang, S. Kondo. G. M. Shivji, C. S. Kim, T. W. Mak, and D. M. Sauder. 1997. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:6148-6155.
24. Pauwels. R. A., G. J. Brusselle, and J. C. Kips. 1997. Cytokine manipulation in animal models of asthma. Am. J. Respir. Crit. Care Med. 156:S78-S81.
25. Colletti, L. M., G. D. Burtch, S. L. Kunkel, R. M. Strieter, K. S. Guice. K. T. Oldham, and D. A. Campbell, Jr. 1990. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49:268-272.
26. Wheeler, A. P., G. Jesmok, and K. L. Brigham. 1990. Tumor necrosis factor's effects on lung mechanics, gas exchange, and airway reactivity in sheep. J. Appl. Physiol. 68:2542-2549.
27. Paggiaro, P., E. Bacci, P. Paoletti, P. Bernard, F. L. Dente, G. Marchetti, D. Talini, G. F. Menconi, and C. Giuntini. 1990. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest 98:536-542.
28. Ebino, K., R. Lemus, and M. H. Karol. 1999. The importance of the diluent for airway transport of toluene diisocyanate following intranasal dosing of mice. Inhal. Toxicol. 11:171-185.
29. Scheerens, H., T. L. Buckley, T. L. Muis, J. Garssen. J. Dormans, F. P. Nijkamp, and H. Van Loveren. 1999. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am. J. Respir. Crit. Care Med. 159:1074-1080.
30. Lange, R. W., R. C. Lantz, D. B. Stolz, S. C. Watkins, P. Sundareshan, R. Lemus, and M. H. Karol. 1999. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicol. Sci. 50:64-71.
31. Mapp, C. E., J. R. Lapa e Silva, R. E. Lucchini, P. Chitano, V. Rado, M. Saetta, M. Pretolani, M. H. Karol, P. Maestrelli. and L. M. Fabbri. 1996. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am. J. Respir. Crit. Care Med. 154:201-208.
32. Scheerens. H., T. L. Buckley. E. M. Davidse. J. Garssen, F. P. Nijkamp, and H. Van Loveren. 1996. Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse. Am. J. Respir. Crit. Care Med. 154:858-865.
33. Cartier, A., L. Grammer, J. L. Malo, F. Lagier, H. Ghezzo, K. Harris, and R. Patterson. 1989. Serum specific antibodies against isocyanates: association with occupational asthma. J. Allergy Clin. Immunol.. 84:507-514.
34. Lummus, Z. L., R. Alam, J. A. Bernstein, and D. I. Bernstein. 1998. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-[alpha] by peripheral mononuclear cells of workers with occupational asthma. J. Allergy Clin. Immunol. 102:265-274.
35. Lushniak, B. D., C. M. Reh, D. I. Bernstein, and J. S. Gallagher. 1998, Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am. J. Ind. Med. 33:471-477.
36. Karol, M H. 1983. Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure. Toxicol. Appl. Pharmacol. 68:229-241.
37. Bernstein, D. I., and A. Jolly. 1999. Current diagnostic methods for diisocyanate induced occupational asthma. Am. J. Ind. Med. 36:459-468.
38. Aul, D. J., A. Bhaumik, A. L. Kennedy, W. E. Brown, J. Lesage, and J.-L. Malo. 1999. Specific IgG response to monomeric and polymeric diphenylmethane diisocyanate conjugates in subjects with respiratory reactions to isocyanates. J. Allergy Clin. Immunol. 103:749-755.
39. Garssen, J., F. P. Nijkamp, H. V. d. Vliet, and H. V. Loveren. 1991. T-cell-mediated induction of airway hyperactivity in mice. Am. Rev. Respir. Dis., 144:931-938.
40. Chung, K. F., and P. J. Barnes. 1999. Cytokines in asthma. Thorax 54:825-857.
41. Cohn, L., J. S. Tepper, and K. Bottomly. 1998. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813-3816.
42. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477-2487.
43. Gelfand, E. W. 1998. Essential role of T lymphocytes in the development of allergen-driven airway hyperresponsiveness. Allergy Asthma Proc. 19:365-369.
44. Grunewald, S. M., A. Werthmann. B. Schnarr, C. E. Klein, E. B. Brocker, M. Mohrs, F. Brombacher, W. Sebald, and A. Duschl 1998. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J. Immunol. 160:4004-4009.
45. Cembrzynska-Nowak, M., E. Szklarz, A. D. Inglot, and J. A. Teodorczyk-Injeyan. 1993. Elevated release of tumor necrosis factor-alpha and interferon -gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 147:291-295.
46. Dabbagh, K., K. Takeyama, H.-M, Lee, I. F. Ueki, J. A. Lausier, and J. A. Nadel. 1999. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 162:6233-6237.
47. Fischer, B. M., L. G. Rochelle, J. A. Voynow, N. J. Akley, and K. B. Adler. 1999. Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 20:413-422.
48. Cohn, L., R. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737-1747.
49. Reischl, I. G. 2000. Dendritic cells and lung antigen responses. Clin. Exp. Allergy 30:214-224.
50. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
51. Kimber, I., R. J. Dearman, M. Cumberbatch, and R. J. D. Huby. 1998. Langerhans cells and chemical allergy. Curr. Opin. Immunol. 10:614-619.
52. Wang, B., S. Kondo, G. M. Shivji, H. Fujisawa, T. W. Mak, and D. N. Sauder. 1996. Tumor necrosis factor receptor II (P75) signalling is required for the migration of Langerhans' cells. Immunology 88:284-288.